Fat hormones linked to MS severity and brain health

Credibility

Interest

Key Takeaway

Certain hormones made by fat tissue are linked to MS severity and brain changes, and these links are not just due to body weight.

What They Found

The study measured three hormones from fat tissue—adiponectin, leptin, and resistin—in people with MS and in healthy people of the same age. Adiponectin was modestly higher in people with MS, especially in those whose MS had become secondary progressive (a stage with steady worsening). Leptin levels were tied to greater disability on a common MS scale, meaning higher leptin often matched more movement or function problems. Resistin was strongly connected with smaller brain volumes in people with progressive MS, especially in certain gray matter areas that help thinking and movement. These links remained even after the researchers accounted for body mass index (BMI), so the hormone effects seem separate from just being heavier or lighter.

Who Should Care and Why

People with MS should care because these fat hormones might help explain why some people get worse over time and why the brain changes, offering another angle to understand disease course. Caregivers may find it useful because hormone-related changes could someday inform monitoring or support plans, like paying attention to subtle changes in thinking or mobility. Neurologists and MS care teams may use this kind of information in the future to tailor tests or treatments, much like checking blood pressure helps guide heart care. This doesn't mean weight alone causes MS changes; it means body fat releases signals that could affect the brain and disability, similar to how a faulty thermostat affects a whole heating system. People with progressive forms of MS, and those tracking worsening symptoms, may benefit most from further research based on these findings.

Important Considerations

This was a single study in a group of people all born in the same year and mostly from one country, so results may not apply to everyone with MS. The study shows associations (things that go together) but does not prove these hormones cause the changes in MS. More studies are needed before doctors can use these hormone tests to make treatment decisions or predictions for individual patients.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Nutrition Early Research MS Progression

Article Topics:

AdipokinesBMI MRIDisabilityMultiple sclerosis

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News